Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for E2F6
Z-value: 1.55
Motif logo
Transcription factors associated with E2F6
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
E2F6
|
ENSG00000169016.12 | E2F transcription factor 6 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| E2F6 | hg19_v2_chr2_-_11606275_11606289 | 0.21 | 2.1e-03 | Click! |
Activity profile of E2F6 motif
Sorted Z-values of E2F6 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr10_-_97050777 | 21.14 |
ENST00000329399.6
|
PDLIM1
|
PDZ and LIM domain 1 |
| chr2_-_174828892 | 19.83 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
| chr18_+_3449695 | 15.21 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr12_-_58146128 | 14.06 |
ENST00000551800.1
ENST00000549606.1 ENST00000257904.6 |
CDK4
|
cyclin-dependent kinase 4 |
| chr12_-_58146048 | 13.45 |
ENST00000547281.1
ENST00000546489.1 ENST00000552388.1 ENST00000540325.1 ENST00000312990.6 |
CDK4
|
cyclin-dependent kinase 4 |
| chr18_+_29077990 | 13.35 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
| chr3_+_171758344 | 13.33 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
| chr1_+_43148625 | 12.78 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
| chr17_-_76183111 | 12.65 |
ENST00000405273.1
ENST00000590862.1 ENST00000590430.1 ENST00000586613.1 |
TK1
|
thymidine kinase 1, soluble |
| chr8_+_95653427 | 11.75 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr8_+_95653373 | 11.65 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr15_+_63340647 | 11.52 |
ENST00000404484.4
|
TPM1
|
tropomyosin 1 (alpha) |
| chr5_+_95997918 | 11.32 |
ENST00000395812.2
ENST00000395813.1 ENST00000359176.4 ENST00000325674.7 |
CAST
|
calpastatin |
| chr19_+_797443 | 10.84 |
ENST00000394601.4
ENST00000589575.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
| chr6_+_83073952 | 10.69 |
ENST00000543496.1
|
TPBG
|
trophoblast glycoprotein |
| chr4_-_174254823 | 10.59 |
ENST00000438704.2
|
HMGB2
|
high mobility group box 2 |
| chr5_+_135364584 | 10.49 |
ENST00000442011.2
ENST00000305126.8 |
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
| chr15_+_63340734 | 10.14 |
ENST00000560959.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr5_+_68462837 | 10.13 |
ENST00000256442.5
|
CCNB1
|
cyclin B1 |
| chr2_-_20424844 | 10.07 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
| chr2_+_10262857 | 9.96 |
ENST00000304567.5
|
RRM2
|
ribonucleotide reductase M2 |
| chr12_-_92539614 | 9.93 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
| chr8_-_67525473 | 9.92 |
ENST00000522677.3
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
| chr11_-_46142615 | 9.89 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr19_+_797392 | 9.87 |
ENST00000350092.4
ENST00000349038.4 ENST00000586481.1 ENST00000585535.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
| chr2_+_172778952 | 9.82 |
ENST00000392584.1
ENST00000264108.4 |
HAT1
|
histone acetyltransferase 1 |
| chr5_+_95998070 | 9.81 |
ENST00000421689.2
ENST00000510756.1 ENST00000512620.1 |
CAST
|
calpastatin |
| chr7_+_116165038 | 9.75 |
ENST00000393470.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr10_-_33247124 | 9.52 |
ENST00000414670.1
ENST00000302278.3 ENST00000374956.4 ENST00000488494.1 ENST00000417122.2 ENST00000474568.1 |
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
| chr8_-_101734308 | 9.34 |
ENST00000519004.1
ENST00000519363.1 ENST00000520142.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr7_+_94023873 | 9.30 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
| chr6_-_10412600 | 9.28 |
ENST00000379608.3
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr9_-_35691017 | 9.10 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
| chr3_-_185542817 | 8.97 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr8_-_101734170 | 8.95 |
ENST00000522387.1
ENST00000518196.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr12_-_56122426 | 8.85 |
ENST00000551173.1
|
CD63
|
CD63 molecule |
| chr7_+_143078652 | 8.83 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
| chr3_-_98620500 | 8.72 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
| chr1_+_154947148 | 8.65 |
ENST00000368436.1
ENST00000308987.5 |
CKS1B
|
CDC28 protein kinase regulatory subunit 1B |
| chr14_-_69445793 | 8.61 |
ENST00000538545.2
ENST00000394419.4 |
ACTN1
|
actinin, alpha 1 |
| chr11_+_4116054 | 8.56 |
ENST00000423050.2
|
RRM1
|
ribonucleotide reductase M1 |
| chr1_+_154947126 | 8.53 |
ENST00000368439.1
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B |
| chr18_+_3449821 | 8.50 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr12_+_69633372 | 8.46 |
ENST00000456847.3
ENST00000266679.8 |
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa |
| chr11_+_4116005 | 8.43 |
ENST00000300738.5
|
RRM1
|
ribonucleotide reductase M1 |
| chr10_-_126849588 | 8.31 |
ENST00000411419.2
|
CTBP2
|
C-terminal binding protein 2 |
| chr10_-_126849068 | 8.28 |
ENST00000494626.2
ENST00000337195.5 |
CTBP2
|
C-terminal binding protein 2 |
| chrX_-_129244454 | 8.26 |
ENST00000308167.5
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
| chrX_-_129244655 | 8.16 |
ENST00000335997.7
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
| chr1_+_156052354 | 8.03 |
ENST00000368301.2
|
LMNA
|
lamin A/C |
| chr15_+_63340553 | 8.02 |
ENST00000334895.5
|
TPM1
|
tropomyosin 1 (alpha) |
| chr16_-_12009833 | 7.95 |
ENST00000420576.2
|
GSPT1
|
G1 to S phase transition 1 |
| chrX_+_114795489 | 7.91 |
ENST00000355899.3
ENST00000537301.1 ENST00000289290.3 |
PLS3
|
plastin 3 |
| chr9_-_113018746 | 7.80 |
ENST00000374515.5
|
TXN
|
thioredoxin |
| chr5_+_177631497 | 7.78 |
ENST00000358344.3
|
HNRNPAB
|
heterogeneous nuclear ribonucleoprotein A/B |
| chr7_-_105752651 | 7.71 |
ENST00000470347.1
ENST00000455385.2 |
SYPL1
|
synaptophysin-like 1 |
| chr2_-_20425158 | 7.67 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
| chr9_-_113018835 | 7.66 |
ENST00000374517.5
|
TXN
|
thioredoxin |
| chr4_-_39529049 | 7.63 |
ENST00000501493.2
ENST00000509391.1 ENST00000507089.1 |
UGDH
|
UDP-glucose 6-dehydrogenase |
| chr8_+_95653302 | 7.44 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr11_-_46142948 | 7.39 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
| chr5_+_95997769 | 7.38 |
ENST00000338252.3
ENST00000508830.1 |
CAST
|
calpastatin |
| chr2_-_10588630 | 7.32 |
ENST00000234111.4
|
ODC1
|
ornithine decarboxylase 1 |
| chr3_+_180630444 | 7.27 |
ENST00000491062.1
ENST00000468861.1 ENST00000445140.2 ENST00000484958.1 |
FXR1
|
fragile X mental retardation, autosomal homolog 1 |
| chr13_-_110959478 | 7.27 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
| chr11_+_46402583 | 7.24 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr16_+_31483451 | 7.20 |
ENST00000565360.1
ENST00000361773.3 |
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
| chr11_-_67169253 | 7.17 |
ENST00000527663.1
ENST00000312989.7 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
| chr7_-_105752971 | 7.16 |
ENST00000011473.2
|
SYPL1
|
synaptophysin-like 1 |
| chr1_+_226250379 | 7.15 |
ENST00000366815.3
ENST00000366814.3 |
H3F3A
|
H3 histone, family 3A |
| chr9_+_137533615 | 7.13 |
ENST00000371817.3
|
COL5A1
|
collagen, type V, alpha 1 |
| chr17_+_42634844 | 7.10 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr15_+_63340858 | 7.07 |
ENST00000560615.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr5_+_177631523 | 7.07 |
ENST00000506339.1
ENST00000355836.5 ENST00000514633.1 ENST00000515193.1 ENST00000506259.1 ENST00000504898.1 |
HNRNPAB
|
heterogeneous nuclear ribonucleoprotein A/B |
| chr9_+_2622085 | 7.06 |
ENST00000382099.2
|
VLDLR
|
very low density lipoprotein receptor |
| chr15_-_60690163 | 7.03 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
| chr1_-_87380002 | 6.99 |
ENST00000331835.5
|
SEP15
|
Homo sapiens 15 kDa selenoprotein (SEP15), transcript variant 2, mRNA. |
| chr15_+_63340775 | 6.95 |
ENST00000559281.1
ENST00000317516.7 |
TPM1
|
tropomyosin 1 (alpha) |
| chr9_+_131452239 | 6.75 |
ENST00000372688.4
ENST00000372686.5 |
SET
|
SET nuclear oncogene |
| chr12_-_50677255 | 6.75 |
ENST00000551691.1
ENST00000394943.3 ENST00000341247.4 |
LIMA1
|
LIM domain and actin binding 1 |
| chr19_-_291365 | 6.68 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr17_-_48943706 | 6.59 |
ENST00000499247.2
|
TOB1
|
transducer of ERBB2, 1 |
| chr5_-_134369973 | 6.59 |
ENST00000265340.7
|
PITX1
|
paired-like homeodomain 1 |
| chr9_-_14313641 | 6.58 |
ENST00000380953.1
|
NFIB
|
nuclear factor I/B |
| chr1_+_43148059 | 6.56 |
ENST00000321358.7
ENST00000332220.6 |
YBX1
|
Y box binding protein 1 |
| chr20_+_44098385 | 6.54 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
| chr8_-_121457608 | 6.54 |
ENST00000306185.3
|
MRPL13
|
mitochondrial ribosomal protein L13 |
| chr12_-_56122761 | 6.53 |
ENST00000552164.1
ENST00000420846.3 ENST00000257857.4 |
CD63
|
CD63 molecule |
| chr15_+_45926919 | 6.44 |
ENST00000561735.1
ENST00000260324.7 |
SQRDL
|
sulfide quinone reductase-like (yeast) |
| chr1_+_27022839 | 6.44 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
| chr7_-_99698338 | 6.42 |
ENST00000354230.3
ENST00000425308.1 |
MCM7
|
minichromosome maintenance complex component 7 |
| chr14_+_100705322 | 6.41 |
ENST00000262238.4
|
YY1
|
YY1 transcription factor |
| chr10_+_70661014 | 6.37 |
ENST00000373585.3
|
DDX50
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 |
| chr1_+_27189631 | 6.36 |
ENST00000339276.4
|
SFN
|
stratifin |
| chr11_-_14379997 | 6.33 |
ENST00000526063.1
ENST00000532814.1 |
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
| chr4_-_39529180 | 6.32 |
ENST00000515021.1
ENST00000510490.1 ENST00000316423.6 |
UGDH
|
UDP-glucose 6-dehydrogenase |
| chr5_+_170814803 | 6.31 |
ENST00000521672.1
ENST00000351986.6 ENST00000393820.2 ENST00000523622.1 |
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
| chr11_+_125462690 | 6.26 |
ENST00000392708.4
ENST00000529196.1 ENST00000531491.1 |
STT3A
|
STT3A, subunit of the oligosaccharyltransferase complex (catalytic) |
| chr14_-_69445968 | 6.25 |
ENST00000438964.2
|
ACTN1
|
actinin, alpha 1 |
| chr10_-_33246722 | 6.21 |
ENST00000437302.1
ENST00000396033.2 |
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
| chr11_-_67169265 | 6.19 |
ENST00000358239.4
ENST00000376745.4 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
| chr22_+_43547937 | 6.14 |
ENST00000329563.4
|
TSPO
|
translocator protein (18kDa) |
| chr16_+_31483374 | 6.11 |
ENST00000394863.3
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
| chrX_-_128657457 | 6.09 |
ENST00000371121.3
ENST00000371123.1 ENST00000371122.4 |
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
| chr10_+_75910960 | 6.07 |
ENST00000539909.1
ENST00000286621.2 |
ADK
|
adenosine kinase |
| chr3_+_179280668 | 6.04 |
ENST00000429709.2
ENST00000450518.2 ENST00000392662.1 ENST00000490364.1 |
ACTL6A
|
actin-like 6A |
| chr20_+_44098346 | 6.02 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
| chr5_+_72112470 | 6.00 |
ENST00000447967.2
ENST00000523768.1 |
TNPO1
|
transportin 1 |
| chr16_-_10674528 | 5.98 |
ENST00000359543.3
|
EMP2
|
epithelial membrane protein 2 |
| chr22_-_36784035 | 5.97 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
| chr1_-_184943610 | 5.96 |
ENST00000367511.3
|
FAM129A
|
family with sequence similarity 129, member A |
| chr3_-_136471204 | 5.95 |
ENST00000480733.1
ENST00000383202.2 ENST00000236698.5 ENST00000434713.2 |
STAG1
|
stromal antigen 1 |
| chr2_-_216300784 | 5.94 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr12_+_6309517 | 5.94 |
ENST00000382519.4
ENST00000009180.4 |
CD9
|
CD9 molecule |
| chr2_-_161350305 | 5.91 |
ENST00000348849.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
| chr2_+_201676908 | 5.90 |
ENST00000409226.1
ENST00000452790.2 |
BZW1
|
basic leucine zipper and W2 domains 1 |
| chr12_+_69633407 | 5.89 |
ENST00000551516.1
|
CPSF6
|
cleavage and polyadenylation specific factor 6, 68kDa |
| chr7_+_77166592 | 5.89 |
ENST00000248594.6
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
| chr15_+_96875657 | 5.88 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr19_-_40331345 | 5.86 |
ENST00000597224.1
|
FBL
|
fibrillarin |
| chr17_-_4852243 | 5.85 |
ENST00000225655.5
|
PFN1
|
profilin 1 |
| chr10_+_21823079 | 5.84 |
ENST00000377100.3
ENST00000377072.3 ENST00000446906.2 |
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
| chr3_+_37903432 | 5.82 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
| chr8_+_110346546 | 5.82 |
ENST00000521662.1
ENST00000521688.1 ENST00000520147.1 |
ENY2
|
enhancer of yellow 2 homolog (Drosophila) |
| chr13_+_110959598 | 5.82 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
| chr14_-_69446034 | 5.81 |
ENST00000193403.6
|
ACTN1
|
actinin, alpha 1 |
| chr12_-_112856623 | 5.79 |
ENST00000551291.2
|
RPL6
|
ribosomal protein L6 |
| chr4_+_57302297 | 5.78 |
ENST00000399688.3
ENST00000512576.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
| chrX_-_118925600 | 5.76 |
ENST00000361575.3
|
RPL39
|
ribosomal protein L39 |
| chrX_-_106243451 | 5.66 |
ENST00000355610.4
ENST00000535534.1 |
MORC4
|
MORC family CW-type zinc finger 4 |
| chr4_-_174256276 | 5.59 |
ENST00000296503.5
|
HMGB2
|
high mobility group box 2 |
| chr2_-_190044480 | 5.57 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
| chr20_+_31350184 | 5.54 |
ENST00000328111.2
ENST00000353855.2 ENST00000348286.2 |
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta |
| chr13_+_73632897 | 5.51 |
ENST00000377687.4
|
KLF5
|
Kruppel-like factor 5 (intestinal) |
| chr1_-_154943212 | 5.50 |
ENST00000368445.5
ENST00000448116.2 ENST00000368449.4 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
| chr17_-_56084578 | 5.48 |
ENST00000582730.2
ENST00000584773.1 ENST00000585096.1 ENST00000258962.4 |
SRSF1
|
serine/arginine-rich splicing factor 1 |
| chr1_-_154943002 | 5.47 |
ENST00000606391.1
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
| chr15_-_64673630 | 5.47 |
ENST00000558008.1
ENST00000559519.1 ENST00000380258.2 |
KIAA0101
|
KIAA0101 |
| chr3_+_52719936 | 5.46 |
ENST00000418458.1
ENST00000394799.2 |
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar) |
| chr5_+_126112794 | 5.44 |
ENST00000261366.5
ENST00000395354.1 |
LMNB1
|
lamin B1 |
| chr11_+_46402744 | 5.44 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr9_-_21994344 | 5.42 |
ENST00000530628.2
ENST00000361570.3 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr2_+_217498105 | 5.41 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
| chr9_+_131451480 | 5.31 |
ENST00000322030.8
|
SET
|
SET nuclear oncogene |
| chr1_-_68299130 | 5.31 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
| chr2_-_153574480 | 5.29 |
ENST00000410080.1
|
PRPF40A
|
PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
| chr8_+_128748308 | 5.24 |
ENST00000377970.2
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
| chr6_-_17706618 | 5.24 |
ENST00000262077.2
ENST00000537253.1 |
NUP153
|
nucleoporin 153kDa |
| chr6_+_7541845 | 5.24 |
ENST00000418664.2
|
DSP
|
desmoplakin |
| chr1_+_113161778 | 5.24 |
ENST00000263168.3
|
CAPZA1
|
capping protein (actin filament) muscle Z-line, alpha 1 |
| chr15_+_96873921 | 5.24 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr4_+_39699664 | 5.20 |
ENST00000261427.5
ENST00000510934.1 ENST00000295963.6 |
UBE2K
|
ubiquitin-conjugating enzyme E2K |
| chr21_+_47401650 | 5.17 |
ENST00000361866.3
|
COL6A1
|
collagen, type VI, alpha 1 |
| chr19_+_6361754 | 5.16 |
ENST00000597326.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
| chr12_-_51663959 | 5.14 |
ENST00000604188.1
ENST00000398453.3 |
SMAGP
|
small cell adhesion glycoprotein |
| chr12_-_51663728 | 5.14 |
ENST00000603864.1
ENST00000605426.1 |
SMAGP
|
small cell adhesion glycoprotein |
| chr11_-_14380664 | 5.10 |
ENST00000545643.1
ENST00000256196.4 |
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
| chr12_-_51664058 | 5.09 |
ENST00000605627.1
|
SMAGP
|
small cell adhesion glycoprotein |
| chr17_+_49243639 | 5.06 |
ENST00000512737.1
ENST00000503064.1 |
NME1-NME2
|
NME1-NME2 readthrough |
| chr2_-_38978492 | 5.05 |
ENST00000409276.1
ENST00000446327.2 ENST00000313117.6 |
SRSF7
|
serine/arginine-rich splicing factor 7 |
| chr6_+_12012536 | 5.04 |
ENST00000379388.2
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
| chr10_-_121302195 | 5.04 |
ENST00000369103.2
|
RGS10
|
regulator of G-protein signaling 10 |
| chr20_+_35807449 | 5.02 |
ENST00000237530.6
|
RPN2
|
ribophorin II |
| chr7_-_148581251 | 5.02 |
ENST00000478654.1
ENST00000460911.1 ENST00000350995.2 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
| chr19_-_11308190 | 5.02 |
ENST00000586659.1
ENST00000592903.1 ENST00000589359.1 ENST00000588724.1 ENST00000432929.2 |
KANK2
|
KN motif and ankyrin repeat domains 2 |
| chr10_-_33623826 | 5.00 |
ENST00000374867.2
|
NRP1
|
neuropilin 1 |
| chr4_-_177713788 | 4.96 |
ENST00000280193.2
|
VEGFC
|
vascular endothelial growth factor C |
| chr17_-_58469474 | 4.95 |
ENST00000300896.4
|
USP32
|
ubiquitin specific peptidase 32 |
| chr10_-_17659357 | 4.94 |
ENST00000326961.6
ENST00000361271.3 |
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
| chr20_-_2451395 | 4.94 |
ENST00000339610.6
ENST00000381342.2 ENST00000438552.2 |
SNRPB
|
small nuclear ribonucleoprotein polypeptides B and B1 |
| chr11_+_12399071 | 4.94 |
ENST00000539723.1
ENST00000550549.1 |
PARVA
|
parvin, alpha |
| chr4_+_174089904 | 4.92 |
ENST00000265000.4
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
| chr10_+_21823243 | 4.90 |
ENST00000307729.7
ENST00000377091.2 |
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
| chr7_+_26240776 | 4.90 |
ENST00000337620.4
|
CBX3
|
chromobox homolog 3 |
| chr1_-_153517473 | 4.88 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
| chr8_+_128748466 | 4.85 |
ENST00000524013.1
ENST00000520751.1 |
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
| chr1_-_154946825 | 4.84 |
ENST00000368453.4
ENST00000368450.1 ENST00000366442.2 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
| chr12_-_54813229 | 4.84 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr9_+_110045537 | 4.83 |
ENST00000358015.3
|
RAD23B
|
RAD23 homolog B (S. cerevisiae) |
| chr18_+_3261883 | 4.82 |
ENST00000237500.5
|
MYL12B
|
myosin, light chain 12B, regulatory |
| chr16_+_29817399 | 4.81 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr18_+_19749386 | 4.80 |
ENST00000269216.3
|
GATA6
|
GATA binding protein 6 |
| chr9_+_100745615 | 4.80 |
ENST00000339399.4
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
| chr19_-_8070474 | 4.78 |
ENST00000407627.2
ENST00000593807.1 |
ELAVL1
|
ELAV like RNA binding protein 1 |
| chr2_-_61697862 | 4.78 |
ENST00000398571.2
|
USP34
|
ubiquitin specific peptidase 34 |
| chr19_-_2050852 | 4.75 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr2_-_85641162 | 4.75 |
ENST00000447219.2
ENST00000409670.1 ENST00000409724.1 |
CAPG
|
capping protein (actin filament), gelsolin-like |
| chr1_+_26798955 | 4.75 |
ENST00000361427.5
|
HMGN2
|
high mobility group nucleosomal binding domain 2 |
| chr5_+_34656569 | 4.75 |
ENST00000428746.2
|
RAI14
|
retinoic acid induced 14 |
| chr7_+_116139424 | 4.74 |
ENST00000222693.4
|
CAV2
|
caveolin 2 |
| chr1_+_165796753 | 4.74 |
ENST00000367879.4
|
UCK2
|
uridine-cytidine kinase 2 |
| chr2_-_178129853 | 4.72 |
ENST00000397062.3
|
NFE2L2
|
nuclear factor, erythroid 2-like 2 |
| chr16_-_65155979 | 4.71 |
ENST00000562325.1
ENST00000268603.4 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr11_+_74660278 | 4.70 |
ENST00000263672.6
ENST00000530257.1 ENST00000526361.1 ENST00000532972.1 |
SPCS2
|
signal peptidase complex subunit 2 homolog (S. cerevisiae) |
| chr19_+_19496624 | 4.68 |
ENST00000494516.2
ENST00000360315.3 ENST00000252577.5 |
GATAD2A
|
GATA zinc finger domain containing 2A |
| chrX_+_109245863 | 4.66 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
| chr14_+_23340822 | 4.65 |
ENST00000359591.4
|
LRP10
|
low density lipoprotein receptor-related protein 10 |
| chr9_-_112260531 | 4.65 |
ENST00000374541.2
ENST00000262539.3 |
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
| chr4_+_57301896 | 4.62 |
ENST00000514888.1
ENST00000264221.2 ENST00000505164.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
| chr3_+_196466710 | 4.60 |
ENST00000327134.3
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of E2F6
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.9 | 17.7 | GO:0048627 | myoblast development(GO:0048627) |
| 5.5 | 27.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 5.5 | 43.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 4.4 | 17.6 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 4.3 | 21.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 4.3 | 17.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 4.2 | 16.8 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 3.8 | 23.1 | GO:0030421 | defecation(GO:0030421) |
| 3.7 | 11.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 3.7 | 18.5 | GO:0003164 | His-Purkinje system development(GO:0003164) |
| 3.5 | 24.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 3.3 | 13.4 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 3.3 | 19.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 3.3 | 9.8 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 3.2 | 12.6 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 3.2 | 9.5 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 3.1 | 3.1 | GO:0071283 | cellular response to iron(III) ion(GO:0071283) |
| 3.0 | 12.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 3.0 | 6.0 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 3.0 | 14.9 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 2.8 | 11.1 | GO:0009956 | radial pattern formation(GO:0009956) |
| 2.6 | 7.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 2.5 | 2.5 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 2.5 | 12.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 2.5 | 22.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 2.4 | 2.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 2.4 | 2.4 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 2.4 | 4.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 2.4 | 33.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 2.3 | 7.0 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 2.3 | 11.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 2.3 | 9.0 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 2.3 | 6.8 | GO:0071789 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 2.2 | 6.7 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 2.2 | 13.4 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 2.2 | 6.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 2.2 | 10.9 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 2.2 | 10.9 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 2.2 | 10.8 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 2.2 | 15.1 | GO:2000795 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 2.2 | 12.9 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 2.1 | 4.3 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 2.1 | 6.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 2.1 | 6.2 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 2.0 | 8.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 2.0 | 6.1 | GO:0044209 | AMP salvage(GO:0044209) |
| 2.0 | 2.0 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 2.0 | 10.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 2.0 | 8.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 1.9 | 5.7 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.9 | 5.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 1.9 | 14.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 1.9 | 29.6 | GO:0051639 | actin filament network formation(GO:0051639) |
| 1.8 | 9.2 | GO:0021759 | globus pallidus development(GO:0021759) |
| 1.8 | 16.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.8 | 8.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.8 | 5.3 | GO:0048382 | mesendoderm development(GO:0048382) |
| 1.8 | 7.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 1.8 | 5.3 | GO:0046732 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.8 | 5.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 1.8 | 22.8 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 1.7 | 6.9 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.7 | 17.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 1.7 | 17.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 1.7 | 11.8 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.7 | 5.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.7 | 8.3 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 1.6 | 13.2 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 1.6 | 16.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 1.6 | 9.8 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
| 1.6 | 16.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.6 | 4.8 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 1.6 | 3.1 | GO:0060066 | oviduct development(GO:0060066) |
| 1.5 | 25.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 1.5 | 4.5 | GO:1900060 | glucosylceramide biosynthetic process(GO:0006679) negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 1.5 | 5.9 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 1.5 | 5.9 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 1.5 | 4.4 | GO:1903377 | B-1 B cell homeostasis(GO:0001922) neural fold elevation formation(GO:0021502) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.4 | 4.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 1.4 | 5.8 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 1.4 | 17.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 1.4 | 1.4 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 1.4 | 9.9 | GO:0070836 | caveola assembly(GO:0070836) |
| 1.4 | 4.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 1.4 | 16.5 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 1.4 | 28.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 1.3 | 5.4 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle recycling(GO:1903422) |
| 1.3 | 4.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.3 | 2.6 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 1.3 | 2.6 | GO:1903308 | regulation of chromatin modification(GO:1903308) |
| 1.3 | 3.9 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 1.3 | 5.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.3 | 5.1 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 1.3 | 5.1 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 1.3 | 6.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 1.3 | 10.0 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 1.2 | 3.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.2 | 3.7 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 1.2 | 3.7 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 1.2 | 3.7 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.2 | 3.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.2 | 2.4 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
| 1.2 | 3.6 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 1.2 | 8.3 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 1.2 | 4.7 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 1.2 | 3.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.2 | 9.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.1 | 2.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 1.1 | 3.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 1.1 | 4.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 1.1 | 3.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 1.1 | 3.3 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.1 | 20.0 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 1.1 | 1.1 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 1.1 | 9.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 1.1 | 8.7 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
| 1.1 | 2.2 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 1.1 | 6.5 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
| 1.1 | 1.1 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 1.1 | 6.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 1.1 | 3.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 1.1 | 12.6 | GO:0060430 | lung saccule development(GO:0060430) |
| 1.0 | 4.2 | GO:2000230 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.0 | 3.1 | GO:1901355 | response to rapamycin(GO:1901355) |
| 1.0 | 7.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 1.0 | 3.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 1.0 | 10.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 1.0 | 3.0 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 1.0 | 3.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.0 | 3.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.0 | 13.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 1.0 | 5.8 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 1.0 | 2.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.9 | 2.8 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.9 | 2.8 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
| 0.9 | 2.8 | GO:0045658 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.9 | 3.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.9 | 0.9 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.9 | 3.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.9 | 12.1 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.9 | 5.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.9 | 1.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.9 | 2.8 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.9 | 7.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.9 | 3.5 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.9 | 6.1 | GO:0010940 | response to vitamin B1(GO:0010266) positive regulation of necrotic cell death(GO:0010940) |
| 0.9 | 5.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.9 | 1.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.9 | 2.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.9 | 9.5 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.9 | 2.6 | GO:0086054 | pulmonary valve formation(GO:0003193) atrial ventricular junction remodeling(GO:0003294) foramen ovale closure(GO:0035922) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.9 | 3.4 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
| 0.8 | 9.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.8 | 5.9 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.8 | 3.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.8 | 3.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.8 | 4.1 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.8 | 2.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.8 | 4.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.8 | 4.0 | GO:0030047 | actin modification(GO:0030047) |
| 0.8 | 5.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.8 | 5.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.8 | 7.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.8 | 6.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.8 | 2.3 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.8 | 0.8 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.8 | 4.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.8 | 5.3 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.7 | 3.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.7 | 4.5 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.7 | 5.9 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.7 | 8.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.7 | 3.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.7 | 4.4 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.7 | 5.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.7 | 4.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.7 | 9.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.7 | 1.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.7 | 2.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.7 | 4.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.7 | 5.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.7 | 14.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.7 | 2.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.7 | 15.6 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 0.7 | 2.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.7 | 1.3 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.7 | 1.3 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.6 | 2.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.6 | 2.6 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.6 | 5.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.6 | 3.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.6 | 2.5 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.6 | 3.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.6 | 2.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.6 | 8.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.6 | 2.5 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.6 | 1.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.6 | 4.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.6 | 3.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.6 | 2.4 | GO:0048749 | compound eye development(GO:0048749) |
| 0.6 | 3.0 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.6 | 2.4 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.6 | 9.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.6 | 1.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.6 | 5.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.6 | 1.7 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.6 | 1.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.6 | 2.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
| 0.6 | 2.8 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.6 | 3.4 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.6 | 6.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.6 | 6.7 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.6 | 4.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.6 | 1.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.5 | 4.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.5 | 2.7 | GO:0032383 | dolichol metabolic process(GO:0019348) regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.5 | 5.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.5 | 2.7 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.5 | 1.1 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
| 0.5 | 2.7 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.5 | 1.6 | GO:1904640 | response to methionine(GO:1904640) |
| 0.5 | 3.2 | GO:0032328 | alanine transport(GO:0032328) |
| 0.5 | 5.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.5 | 2.6 | GO:0015862 | uridine transport(GO:0015862) |
| 0.5 | 1.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.5 | 3.6 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.5 | 2.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.5 | 1.5 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.5 | 7.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.5 | 4.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.5 | 1.5 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.5 | 4.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.5 | 1.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.5 | 3.4 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.5 | 4.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.5 | 2.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.5 | 1.9 | GO:0072284 | metanephric S-shaped body morphogenesis(GO:0072284) |
| 0.5 | 1.4 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.5 | 0.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.5 | 7.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.5 | 3.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.5 | 1.4 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.5 | 0.9 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.5 | 13.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.5 | 6.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.5 | 4.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.5 | 1.4 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.5 | 4.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.5 | 1.4 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) positive regulation of cGMP metabolic process(GO:0030825) |
| 0.5 | 5.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.5 | 1.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.4 | 4.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.4 | 0.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.4 | 4.9 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.4 | 12.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.4 | 6.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.4 | 1.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 | 1.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.4 | 1.7 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.4 | 13.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.4 | 1.7 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.4 | 1.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.4 | 37.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.4 | 3.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.4 | 5.9 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.4 | 2.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.4 | 4.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.4 | 2.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.4 | 2.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.4 | 2.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.4 | 1.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.4 | 9.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.4 | 3.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.4 | 3.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 | 2.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.4 | 2.0 | GO:0036344 | platelet morphogenesis(GO:0036344) |
| 0.4 | 1.2 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.4 | 2.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.4 | 1.6 | GO:0072642 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.4 | 3.1 | GO:0003157 | endocardium development(GO:0003157) |
| 0.4 | 2.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.4 | 1.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.4 | 7.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.4 | 1.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.4 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 | 1.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.4 | 0.8 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.4 | 1.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 | 0.4 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.4 | 1.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.4 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.4 | 1.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.4 | 6.5 | GO:0045727 | positive regulation of cellular amide metabolic process(GO:0034250) positive regulation of translation(GO:0045727) |
| 0.4 | 0.4 | GO:0099543 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.4 | 10.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.4 | 1.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.4 | 1.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.4 | 3.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.4 | 3.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.4 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.4 | 2.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.4 | 1.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 | 1.5 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.4 | 1.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.4 | 2.9 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.4 | 1.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.4 | 3.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.4 | 1.1 | GO:0050894 | determination of affect(GO:0050894) |
| 0.4 | 1.4 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.4 | 1.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.4 | 0.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.4 | 1.8 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.4 | 1.1 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.4 | 3.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.4 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.4 | 5.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.4 | 2.5 | GO:0061087 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.4 | 4.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.4 | 3.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.4 | 1.1 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
| 0.4 | 1.8 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.3 | 2.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.3 | 2.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 1.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.3 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.3 | 2.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.3 | 1.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 17.0 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.3 | 1.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 | 12.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.3 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 | 1.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.3 | 0.7 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.3 | 3.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 | 1.0 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.3 | 0.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.3 | 1.6 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.3 | 6.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.3 | 5.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.3 | 3.5 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.3 | 13.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.3 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.3 | 5.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.3 | 0.9 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.3 | 4.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.3 | 5.5 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.3 | 6.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 | 0.9 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.3 | 3.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.3 | 1.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.3 | 7.9 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.3 | 16.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.3 | 12.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.3 | 1.8 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.3 | 2.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 | 1.8 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.3 | 2.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.3 | 0.9 | GO:0061325 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) endodermal digestive tract morphogenesis(GO:0061031) cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
| 0.3 | 1.2 | GO:0032489 | aminophospholipid transport(GO:0015917) regulation of Cdc42 protein signal transduction(GO:0032489) regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.3 | 3.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 | 3.2 | GO:0030903 | notochord development(GO:0030903) |
| 0.3 | 1.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.3 | 4.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 | 0.3 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
| 0.3 | 2.6 | GO:0033622 | integrin activation(GO:0033622) |
| 0.3 | 1.1 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 | 2.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.3 | 1.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.3 | 2.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.3 | 3.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.3 | 1.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.3 | 0.8 | GO:0001541 | ovarian follicle development(GO:0001541) |
| 0.3 | 1.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.3 | 1.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 | 1.4 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.3 | 2.2 | GO:0015791 | polyol transport(GO:0015791) |
| 0.3 | 1.4 | GO:0034971 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) histone H3-R17 methylation(GO:0034971) regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 0.3 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.3 | 1.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.3 | 2.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.3 | 3.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.3 | 3.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.3 | 3.4 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.3 | 4.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 | 1.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.3 | 2.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.3 | 0.8 | GO:0060282 | regulation of oocyte development(GO:0060281) positive regulation of oocyte development(GO:0060282) |
| 0.3 | 0.5 | GO:0035936 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.3 | 16.7 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.3 | 0.8 | GO:0070345 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 | 0.8 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.3 | 2.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.3 | 2.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.3 | 1.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.3 | 3.5 | GO:0097205 | renal filtration(GO:0097205) |
| 0.2 | 1.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.2 | 1.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.2 | 1.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 | 1.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 | 3.6 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 | 13.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 | 11.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.2 | 1.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.2 | 2.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 | 4.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 1.7 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 | 4.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 1.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.2 | 0.5 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 0.2 | 1.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 0.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.2 | 1.6 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.2 | 2.3 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.2 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 6.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.2 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 2.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 | 3.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.2 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.2 | 1.6 | GO:0097503 | sialylation(GO:0097503) |
| 0.2 | 1.8 | GO:0001667 | ameboidal-type cell migration(GO:0001667) |
| 0.2 | 4.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 | 1.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.2 | 1.7 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.2 | 3.7 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.2 | 0.9 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.2 | 3.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 2.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.2 | 1.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.2 | 2.1 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.2 | 3.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.2 | 26.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.2 | 1.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 | 3.3 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.2 | 1.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.2 | 0.2 | GO:0061074 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
| 0.2 | 0.4 | GO:1902903 | regulation of fibril organization(GO:1902903) |
| 0.2 | 0.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 | 1.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 | 1.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.2 | 1.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.2 | 2.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 | 1.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.2 | 2.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 0.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 | 1.1 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
| 0.2 | 0.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 | 1.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 0.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 | 0.4 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.2 | 0.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.2 | 4.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.2 | 26.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.2 | 3.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.2 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 | 2.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.2 | 0.5 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.2 | 2.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 | 4.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.2 | 0.7 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.2 | 1.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 | 0.7 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.2 | 0.2 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.2 | 0.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.2 | 1.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 0.5 | GO:0001554 | luteolysis(GO:0001554) |
| 0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 | 0.2 | GO:0051458 | corticotropin secretion(GO:0051458) |
| 0.2 | 1.3 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 | 3.1 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.2 | 1.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 | 1.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.2 | 4.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.2 | 0.5 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.2 | 1.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.2 | 1.1 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.2 | 0.8 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.2 | 0.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.2 | 0.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.2 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.2 | 5.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 | 2.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.2 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.2 | 3.6 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.2 | 1.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 | 8.6 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.2 | 3.2 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.1 | 2.7 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.1 | 2.6 | GO:0097502 | mannosylation(GO:0097502) |
| 0.1 | 1.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 1.9 | GO:0034205 | beta-amyloid formation(GO:0034205) |
| 0.1 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 2.6 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 3.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.1 | 1.0 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 0.1 | 1.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 | 0.8 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.1 | 1.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 | 3.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 0.3 | GO:0010887 | detection of endogenous stimulus(GO:0009726) negative regulation of cholesterol storage(GO:0010887) |
| 0.1 | 0.5 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 | 0.4 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 | 0.4 | GO:0048880 | sensory system development(GO:0048880) |
| 0.1 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 | 3.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 | 0.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 | 0.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.3 | GO:0090238 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 | 0.8 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 1.8 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 | 8.2 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
| 0.1 | 0.6 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 | 4.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.1 | 3.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 0.9 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.1 | 2.5 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.1 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 | 24.4 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.1 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 1.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 3.5 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 1.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 1.8 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.1 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 2.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.2 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 0.2 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 | 0.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.7 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.1 | 3.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 2.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 3.7 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.1 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.1 | 1.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 1.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.1 | 8.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 | 8.0 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.1 | 0.3 | GO:2000282 | negative regulation of cardiac muscle adaptation(GO:0010616) regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of adrenergic receptor signaling pathway(GO:0071878) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.1 | 2.1 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 1.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 1.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 7.4 | GO:0070126 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
| 0.1 | 1.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 1.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 0.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 0.1 | GO:1903911 | positive regulation of receptor clustering(GO:1903911) |
| 0.1 | 1.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.1 | 0.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
| 0.1 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 | 0.9 | GO:0048514 | blood vessel morphogenesis(GO:0048514) |
| 0.1 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 1.7 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 0.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 0.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 2.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 1.6 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
| 0.1 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.1 | 2.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 | 2.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.1 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 2.8 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.1 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
| 0.1 | 0.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 0.1 | 3.8 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 2.1 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.6 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
| 0.1 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.1 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.1 | 5.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.1 | 1.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 0.6 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 1.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 | 0.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 1.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 0.8 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 1.1 | GO:0006260 | DNA replication(GO:0006260) |
| 0.1 | 0.9 | GO:0009409 | response to cold(GO:0009409) |
| 0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.9 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 0.7 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.1 | 1.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 0.3 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.1 | 1.0 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.1 | 0.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 | 0.7 | GO:0060996 | dendritic spine development(GO:0060996) |
| 0.1 | 1.4 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.1 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 1.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.5 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 1.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.1 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 | 1.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 0.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.1 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 3.2 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
| 0.1 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 2.7 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 0.9 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 | 1.1 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.1 | 1.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 1.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 1.7 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 0.3 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.3 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 3.3 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 1.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 0.4 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.1 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.1 | 3.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.1 | 0.1 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
| 0.1 | 1.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.1 | 0.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.2 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.1 | 0.3 | GO:0032057 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 | 0.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.7 | GO:0042113 | B cell activation(GO:0042113) |
| 0.0 | 0.1 | GO:0035733 | hepatic stellate cell activation(GO:0035733) fibroblast activation(GO:0072537) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 | 1.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.9 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.0 | 2.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.0 | 2.2 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.0 | 4.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.1 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) labyrinthine layer morphogenesis(GO:0060713) |
| 0.0 | 0.6 | GO:0019079 | viral genome replication(GO:0019079) |
| 0.0 | 0.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 0.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 | 0.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 | 0.6 | GO:0009994 | oocyte differentiation(GO:0009994) |
| 0.0 | 0.7 | GO:0009880 | embryonic pattern specification(GO:0009880) |
| 0.0 | 0.2 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
| 0.0 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.5 | GO:0007099 | centriole replication(GO:0007099) |
| 0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.7 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.0 | 0.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.0 | 0.9 | GO:0045682 | regulation of epidermis development(GO:0045682) |
| 0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
| 0.0 | 0.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
| 0.0 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 | 0.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.0 | 0.2 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
| 0.0 | 0.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.0 | 1.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.0 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.0 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
| 0.0 | 0.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.0 | 0.5 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.0 | 0.0 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.0 | 0.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.7 | 26.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 6.4 | 19.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 3.9 | 11.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 3.7 | 11.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 3.5 | 28.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 3.0 | 17.8 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 2.9 | 55.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 2.7 | 16.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 2.6 | 10.3 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 2.3 | 21.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 2.3 | 14.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 2.3 | 6.8 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 2.2 | 6.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 2.2 | 32.7 | GO:0005916 | fascia adherens(GO:0005916) |
| 2.1 | 10.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 2.1 | 14.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 2.0 | 10.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 2.0 | 6.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 2.0 | 5.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 2.0 | 19.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 1.9 | 13.4 | GO:0016589 | NURF complex(GO:0016589) |
| 1.9 | 11.4 | GO:0001740 | Barr body(GO:0001740) |
| 1.8 | 14.6 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 1.8 | 14.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 1.7 | 20.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 1.6 | 6.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 1.6 | 6.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 1.5 | 4.5 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 1.5 | 8.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 1.5 | 4.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 1.5 | 7.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 1.4 | 5.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 1.4 | 9.7 | GO:0071203 | WASH complex(GO:0071203) |
| 1.4 | 11.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 1.3 | 4.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 1.3 | 11.9 | GO:0005638 | lamin filament(GO:0005638) |
| 1.3 | 11.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 1.2 | 3.7 | GO:0044305 | calyx of Held(GO:0044305) |
| 1.2 | 7.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.2 | 9.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.2 | 4.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 1.1 | 4.5 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 1.1 | 3.4 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 1.1 | 3.3 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 1.1 | 16.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 1.1 | 7.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 1.1 | 10.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 1.0 | 1.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.0 | 4.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 1.0 | 4.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 1.0 | 13.7 | GO:0045120 | pronucleus(GO:0045120) |
| 1.0 | 11.7 | GO:0097470 | ribbon synapse(GO:0097470) |
| 1.0 | 20.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.9 | 10.4 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.9 | 2.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.9 | 3.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.9 | 4.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.9 | 9.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.9 | 8.7 | GO:0000796 | condensin complex(GO:0000796) |
| 0.9 | 4.3 | GO:0000938 | GARP complex(GO:0000938) |
| 0.8 | 8.0 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.8 | 2.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.8 | 2.4 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.8 | 14.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.8 | 6.9 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.8 | 4.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.7 | 3.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.7 | 4.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.7 | 2.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.7 | 2.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.7 | 8.2 | GO:0090543 | Flemming body(GO:0090543) |
| 0.7 | 4.7 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.7 | 4.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.7 | 2.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.6 | 1.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.6 | 9.0 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.6 | 3.1 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.6 | 1.8 | GO:0044393 | microspike(GO:0044393) |
| 0.6 | 2.3 | GO:0000811 | GINS complex(GO:0000811) |
| 0.6 | 9.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.6 | 8.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.6 | 6.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.6 | 7.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.6 | 14.4 | GO:0030057 | desmosome(GO:0030057) |
| 0.5 | 6.4 | GO:0042555 | MCM complex(GO:0042555) |
| 0.5 | 5.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.5 | 1.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.5 | 1.5 | GO:0031261 | nuclear pre-replicative complex(GO:0005656) DNA replication preinitiation complex(GO:0031261) pre-replicative complex(GO:0036387) |
| 0.5 | 4.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.5 | 8.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.5 | 24.9 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.5 | 23.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.5 | 1.5 | GO:0031523 | Myb complex(GO:0031523) |
| 0.5 | 5.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.5 | 2.9 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.5 | 4.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.5 | 1.5 | GO:0030689 | Noc complex(GO:0030689) |
| 0.5 | 8.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.5 | 11.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.5 | 3.4 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.5 | 1.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.5 | 7.1 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.5 | 4.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.5 | 2.3 | GO:0044754 | autolysosome(GO:0044754) |
| 0.5 | 4.6 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.5 | 4.6 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.5 | 1.8 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.5 | 2.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.5 | 2.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.5 | 4.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.5 | 2.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.4 | 6.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.4 | 5.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.4 | 1.7 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.4 | 3.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.4 | 6.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.4 | 4.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.4 | 4.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.4 | 2.7 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.4 | 35.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.4 | 3.5 | GO:0032059 | bleb(GO:0032059) |
| 0.4 | 10.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.4 | 6.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.4 | 1.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.4 | 42.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.4 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 5.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.4 | 40.6 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.4 | 6.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.4 | 2.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 2.1 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.4 | 33.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 3.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.3 | 2.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.3 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.3 | 1.7 | GO:0030891 | VCB complex(GO:0030891) |
| 0.3 | 1.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.3 | 3.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 1.6 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 2.3 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 8.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.3 | 3.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.3 | 6.1 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.3 | 5.6 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 3.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.3 | 1.5 | GO:0032021 | NELF complex(GO:0032021) |
| 0.3 | 1.2 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 3.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.3 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.3 | 5.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.3 | 8.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 1.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.3 | 3.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 5.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.3 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.3 | 11.3 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.3 | 3.2 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.3 | 3.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.3 | 37.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.3 | 2.3 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 0.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 2.5 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.2 | 4.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 2.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.2 | 1.2 | GO:0051286 | cell tip(GO:0051286) |
| 0.2 | 2.1 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.2 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 4.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 2.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 2.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 2.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 1.1 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.2 | 8.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 5.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.2 | 3.4 | GO:0030018 | Z disc(GO:0030018) |
| 0.2 | 1.6 | GO:0098858 | actin-based cell projection(GO:0098858) |
| 0.2 | 1.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 2.8 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.2 | 3.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.2 | 3.9 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 2.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.2 | 9.1 | GO:0005844 | polysome(GO:0005844) |
| 0.2 | 5.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.2 | 20.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 15.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.2 | 13.9 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 9.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.2 | 3.7 | GO:0005884 | actin filament(GO:0005884) |
| 0.2 | 1.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 1.5 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.2 | 0.7 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.2 | 0.7 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.2 | 7.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.2 | 7.6 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.2 | 1.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 17.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.2 | 2.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 0.3 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.2 | 1.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.2 | 5.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.2 | 4.6 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.2 | 7.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 3.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.2 | 1.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 1.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 1.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 1.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 7.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 6.6 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 15.0 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 8.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 8.3 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 13.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 4.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 0.7 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.1 | 3.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 2.6 | GO:0044447 | axoneme part(GO:0044447) |
| 0.1 | 9.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 7.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 8.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.1 | 1.1 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.1 | 0.4 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 11.8 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 2.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 1.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 2.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 5.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 1.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.1 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 2.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 0.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.1 | 0.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 7.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 13.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.1 | 4.0 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 3.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.1 | 6.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 1.8 | GO:0000785 | chromatin(GO:0000785) |
| 0.1 | 1.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 1.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 2.4 | GO:0005840 | ribosome(GO:0005840) |
| 0.1 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 4.4 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 0.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 0.9 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 1.4 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 20.6 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 2.9 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 1.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
| 0.0 | 0.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.0 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.0 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 1.3 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 16.4 | GO:0016604 | nuclear body(GO:0016604) |
| 0.0 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 1.1 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 1.4 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.0 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 3.0 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.1 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 0.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.0 | 1.1 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.9 | GO:0001650 | fibrillar center(GO:0001650) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.7 | 26.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 4.8 | 28.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 4.2 | 12.6 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 4.0 | 16.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 3.9 | 27.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 3.3 | 9.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 3.1 | 15.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 2.7 | 10.8 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 2.6 | 10.6 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 2.6 | 10.3 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 2.6 | 15.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 2.5 | 17.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 2.4 | 16.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 2.3 | 32.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 2.2 | 15.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 2.1 | 6.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 2.1 | 18.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 2.0 | 20.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 1.8 | 7.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 1.7 | 46.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 1.7 | 8.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 1.5 | 13.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 1.5 | 6.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 1.5 | 4.5 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 1.5 | 9.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.5 | 10.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.5 | 3.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.5 | 3.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 1.4 | 43.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 1.4 | 5.7 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 1.4 | 5.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 1.4 | 4.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 1.4 | 9.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 1.3 | 5.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 1.3 | 11.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 1.3 | 4.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 1.3 | 2.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.3 | 3.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 1.3 | 9.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 1.3 | 10.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 1.2 | 11.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 1.1 | 3.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 1.1 | 3.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 1.1 | 4.5 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 1.1 | 12.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 1.1 | 1.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) ubiquitin-protein transferase activator activity(GO:0097027) |
| 1.1 | 16.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 1.1 | 4.4 | GO:0043398 | HLH domain binding(GO:0043398) |
| 1.1 | 4.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.1 | 36.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 1.1 | 6.4 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 1.1 | 5.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.0 | 11.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.0 | 3.1 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 1.0 | 24.3 | GO:0017166 | vinculin binding(GO:0017166) |
| 1.0 | 5.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 1.0 | 3.9 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 1.0 | 13.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.0 | 41.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 1.0 | 5.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.0 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.9 | 3.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.9 | 5.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.9 | 5.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.9 | 2.8 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.9 | 5.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.9 | 8.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.9 | 4.5 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.9 | 2.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.9 | 6.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.9 | 13.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.9 | 4.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.9 | 2.6 | GO:0086076 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.9 | 3.4 | GO:0038047 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 0.9 | 5.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.8 | 25.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.8 | 4.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.8 | 2.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.8 | 3.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.8 | 1.6 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.8 | 3.2 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.8 | 5.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.8 | 2.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.8 | 3.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.8 | 2.3 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.7 | 21.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.7 | 4.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.7 | 5.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.7 | 0.7 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.7 | 10.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.7 | 3.7 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.7 | 2.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.7 | 66.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.7 | 5.6 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.7 | 5.6 | GO:0005497 | androgen binding(GO:0005497) |
| 0.7 | 7.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.7 | 8.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.7 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.7 | 4.8 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.7 | 21.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.7 | 2.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.7 | 19.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.7 | 13.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.6 | 4.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.6 | 0.6 | GO:0031432 | titin binding(GO:0031432) RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.6 | 9.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.6 | 1.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.6 | 55.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.6 | 4.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.6 | 6.6 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.6 | 3.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.6 | 3.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.6 | 2.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.6 | 4.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
| 0.6 | 3.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.6 | 3.5 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.6 | 1.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.6 | 10.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.6 | 4.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.6 | 2.8 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.6 | 7.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.6 | 1.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.6 | 9.9 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.5 | 4.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.5 | 4.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.5 | 1.6 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.5 | 4.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.5 | 1.6 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.5 | 1.6 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.5 | 1.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.5 | 5.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.5 | 2.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.5 | 5.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.5 | 1.6 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.5 | 4.2 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.5 | 5.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.5 | 3.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.5 | 1.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.5 | 8.1 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.5 | 2.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.5 | 3.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.5 | 1.5 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.5 | 8.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.5 | 3.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.5 | 8.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.5 | 1.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.5 | 0.5 | GO:0032181 | heteroduplex DNA loop binding(GO:0000404) double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.5 | 21.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.5 | 1.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.5 | 0.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.5 | 4.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.5 | 4.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.5 | 33.2 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.5 | 1.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.5 | 50.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.4 | 3.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.4 | 9.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.4 | 1.3 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.4 | 5.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.4 | 1.3 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.4 | 1.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.4 | 4.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.4 | 9.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.4 | 4.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.4 | 3.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.4 | 17.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.4 | 21.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.4 | 2.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.4 | 1.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.4 | 2.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.4 | 4.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.4 | 3.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.4 | 9.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.4 | 7.5 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.4 | 7.4 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.4 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.4 | 1.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.4 | 7.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.4 | 1.2 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.4 | 2.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.4 | 1.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.4 | 3.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.4 | 1.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.4 | 1.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.4 | 4.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.4 | 2.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.4 | 1.1 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.4 | 11.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.4 | 1.8 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.4 | 8.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.4 | 1.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.4 | 0.4 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.3 | 1.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.3 | 1.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.3 | 2.8 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.3 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.3 | 2.7 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.3 | 1.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 4.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.3 | 1.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.3 | 0.7 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.3 | 4.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.3 | 3.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.3 | 8.3 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.3 | 0.9 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.3 | 1.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.3 | 6.0 | GO:0043495 | protein anchor(GO:0043495) |
| 0.3 | 2.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.3 | 2.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.3 | 1.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.3 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.3 | 1.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.3 | 2.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.3 | 0.9 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.3 | 2.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 0.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.3 | 1.5 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.3 | 1.2 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 2.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.3 | 7.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.3 | 1.2 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.3 | 12.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.3 | 2.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.3 | 2.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.3 | 1.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.3 | 4.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.3 | 1.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.3 | 11.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.3 | 3.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.3 | 4.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.3 | 1.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.3 | 8.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.3 | 3.6 | GO:0070888 | E-box binding(GO:0070888) |
| 0.3 | 4.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.3 | 1.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 6.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.3 | 2.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.3 | 2.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.3 | 10.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.2 | 7.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 6.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 11.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 3.6 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.2 | 2.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 1.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.2 | 2.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 40.6 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.2 | 5.2 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.2 | 1.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.2 | 1.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 7.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.2 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.2 | 1.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.2 | 7.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 1.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 0.9 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.2 | 5.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
| 0.2 | 1.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 1.0 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 1.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.2 | 0.6 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.2 | 2.6 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 3.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.2 | 2.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 41.2 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.2 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.2 | 1.0 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.2 | 0.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.2 | 2.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 7.0 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 1.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.2 | 0.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.2 | 1.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 4.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 3.6 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.2 | 0.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.2 | 1.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 1.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.2 | 3.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.2 | 5.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.2 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.2 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.2 | 1.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.2 | 30.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.2 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 2.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 3.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 3.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 3.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 6.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 1.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 2.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 2.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 4.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 0.8 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 1.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 3.8 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.1 | 2.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 4.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 1.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 1.5 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.2 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.1 | 0.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 5.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 2.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 4.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 3.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 3.1 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 6.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 1.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 1.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 0.9 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 2.8 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 1.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 1.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.1 | 9.9 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 0.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 2.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 6.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.4 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.1 | 0.5 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.1 | 4.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
| 0.1 | 0.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.1 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.1 | 0.3 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.1 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 5.5 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.1 | 3.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.1 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.1 | 0.4 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.1 | 1.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 1.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.2 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.1 | 0.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 0.5 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 1.4 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.1 | 0.2 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.1 | 0.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 1.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.1 | 1.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 1.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 2.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 1.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 1.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 9.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 1.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 0.2 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.1 | 1.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.0 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.0 | 0.9 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.0 | 0.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 19.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.0 | 7.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.0 | 4.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.0 | 1.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 2.1 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.0 | 9.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.0 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 3.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.0 | 0.1 | GO:1904047 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) nitrite reductase activity(GO:0098809) S-adenosyl-L-methionine binding(GO:1904047) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 1.1 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.0 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.0 | 4.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.6 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 1.1 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 0.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 1.8 | GO:0003823 | antigen binding(GO:0003823) |
| 0.0 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.9 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.0 | 0.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 43.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 1.5 | 89.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 1.3 | 2.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 1.0 | 66.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 1.0 | 19.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 1.0 | 45.7 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.8 | 20.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.8 | 22.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.7 | 20.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.6 | 18.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.6 | 37.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.6 | 58.5 | PID E2F PATHWAY | E2F transcription factor network |
| 0.6 | 26.3 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.6 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.6 | 6.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.5 | 4.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.5 | 1.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.5 | 18.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.5 | 55.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.5 | 33.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.5 | 19.5 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.4 | 1.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.4 | 13.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.4 | 7.6 | PID ATR PATHWAY | ATR signaling pathway |
| 0.4 | 5.2 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.4 | 4.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.3 | 11.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.3 | 12.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.3 | 12.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.3 | 6.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.3 | 10.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.3 | 2.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.3 | 9.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 11.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.3 | 15.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.3 | 6.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.3 | 29.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.3 | 4.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.3 | 20.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.3 | 2.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.3 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.3 | 22.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.3 | 18.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 8.4 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 3.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 11.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 12.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.2 | 4.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 11.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 7.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 6.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 3.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.2 | 1.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.2 | 6.9 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 2.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 2.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 5.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 6.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 7.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 2.0 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 5.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 1.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 3.6 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 3.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 1.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 1.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 1.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 4.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 12.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 14.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 1.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 5.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 15.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 2.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 2.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 1.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 54.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 1.5 | 43.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 1.3 | 4.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 1.3 | 25.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.2 | 23.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 1.2 | 32.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 1.2 | 17.3 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 1.0 | 29.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 1.0 | 7.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 1.0 | 19.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 1.0 | 16.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 1.0 | 62.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.9 | 60.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.9 | 43.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.9 | 15.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.8 | 53.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.8 | 12.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.8 | 16.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.8 | 14.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.8 | 10.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.8 | 13.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.7 | 13.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.7 | 4.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.7 | 11.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.7 | 23.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.7 | 10.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.7 | 19.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.6 | 3.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.6 | 22.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.6 | 12.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.6 | 6.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.6 | 87.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.6 | 19.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.6 | 18.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.6 | 16.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.5 | 9.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.5 | 12.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.5 | 10.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.5 | 9.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.4 | 4.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.4 | 8.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.4 | 8.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.4 | 9.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.4 | 16.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.4 | 5.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 4.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.4 | 11.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.3 | 2.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 5.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.3 | 12.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.3 | 5.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.3 | 2.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 26.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.3 | 1.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.3 | 5.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.3 | 2.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.3 | 22.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.3 | 6.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.3 | 2.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.3 | 27.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.3 | 5.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.3 | 5.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.3 | 1.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.3 | 21.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.3 | 6.1 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.3 | 3.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.3 | 5.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 5.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 3.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 5.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 6.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 3.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.2 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.2 | 5.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 3.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 4.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 4.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.2 | 3.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.2 | 34.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 4.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.2 | 1.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 2.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.2 | 8.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.2 | 6.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 0.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.2 | 9.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 3.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 3.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 1.9 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.2 | 5.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 4.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 2.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.2 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 2.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.2 | 5.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 1.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.2 | 4.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 3.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 1.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 2.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 4.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.1 | 2.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 5.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 2.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 1.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 3.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 3.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 4.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 6.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 3.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 0.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 4.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 3.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 1.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 0.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.1 | 1.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 3.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 2.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 1.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 1.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 1.5 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
| 0.1 | 2.9 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 1.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.1 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 1.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 2.1 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
| 0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 1.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 0.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.0 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.0 | 4.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.0 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 0.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 2.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |